Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pacira BioSciences Inc shares valued at $64,005 were sold by Ceesay Abraham on Sep 04 ’25. At $27.19 per share, Ceesay Abraham sold 2,354 shares. The insider’s holdings dropped to 9,039 shares worth approximately $0.2 million following the completion of this transaction.
Also, Ceesay Abraham purchased 2,354 shares, netting a total of over 64,005 in proceeds.
Before that, BIGAL MARCELO had sold 4,912 shares from its account. In a trade valued at $116,267, the Director traded Pacira BioSciences Inc shares for $23.67 each. Upon closing the transaction, the insider’s holdings decreased to 4,912 shares, worth approximately $0.25 million.
As published in a research note from Truist on July 25, 2025, Pacira BioSciences Inc [PCRX] has been rated up from a Hold to a Buy and the price target has been revised to $30. Analysts at Truist upgraded the stock from ‘”a Sell”‘ to ‘”a Hold”‘ outlook in a report released in late January. As of August 13, 2024, Truist has decreased its “Buy” rating to a “Sell” for PCRX. Earlier on August 12, 2024, RBC Capital Mkts downgraded its rating. Their new recommendation was “a Sector perform” for PCRX stock which previously was a “an Outperform”.
Analyzing PCRX Stock Performance
On last trading session, Pacira BioSciences Inc [NASDAQ: PCRX] plunged -2.63% to $21.85. The stock’s lowest price that day was $21.605, but it reached a high of $22.7 in the same session. During the last five days, there has been a surge of approximately 4.00%. Over the course of the year, Pacira BioSciences Inc shares have jumped approximately 31.86%. Shares of the company reached a 52-week high of $27.64 on 09/03/25 and a 52-week low of $18.17 on 01/06/25.
Support And Resistance Levels for Pacira BioSciences Inc (PCRX)
According to the 24-hour chart, there is a support level at 21.40, which, if violated, would cause prices to drop to 20.95. In the upper region, resistance lies at 22.50. The next price resistance is at 23.15. RSI (Relative Strength Index) is 41.33 on the 14-day chart, showing neutral technical sentiment.
Is Pacira BioSciences Inc subject to short interest?
Stocks of Pacira BioSciences Inc saw a sharp steep in short interest on 2025-10-15 dropping by -0.74 million shares to 5.95 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 6.69 million shares. A decline of -12.43% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 11.23 of the overall float, the days-to-cover ratio (short ratio) decline to 11.23.
Which companies own the most shares of Pacira BioSciences Inc (PCRX)?
In terms of Pacira BioSciences Inc share price expectations, FactSet research, analysts set an average price target of 25 in the next 12 months, up nearly 11.41% from the previous closing price of $22.44. Analysts anticipate Pacira BioSciences Inc stock to reach 63 by 2025, with the lowest price target being 12. In spite of this, 6 analysts ranked Pacira BioSciences Inc stock as Buy at the end of 2025.
